Genomics is transforming how researchers uncover the genetic basis of disease, improve diagnostic accuracy, and develop the next generation of precision therapies. Our latest Industry Focus eBook, sponsored by Illumina, brings together expert perspectives and recent research exploring advances in rare-disease genomics, whole-genome sequencing, gene regulation, and CRISPR technologies.
Inside, you'll discover how new approaches are improving rare disease genomics and expanding access to long-range genomic information, alongside the latest innovations in whole-genome sequencing that are helping researchers generate more comprehensive and accurate genomic insights.
The eBook also explores emerging discoveries in gene regulation, including the role of small non-coding RNAs and mobile genetic elements, while highlighting the rapid evolution of CRISPR technologies. From DNA methylation-responsive enzymes to safer DNA-nicking approaches and RNA-targeting CRISPR systems, these advances are broadening the possibilities for gene editing and therapeutic development.
Whether you work in genomics research, clinical genetics, biotechnology, or translational medicine, this collection provides valuable insights into the technologies and discoveries shaping the future of genomic science.
Download your free copy to explore these topics in greater depth and discover how the latest innovations are advancing genomic research and precision medicine.
About Illumina, Inc.
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission-critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.